HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Purinergic receptors in ocular inflammation.

Abstract
Inflammation is a complex process that implies the interaction between cells and molecular mediators, which, when not properly "tuned," can lead to disease. When inflammation affects the eye, it can produce severe disorders affecting the superficial and internal parts of the visual organ. The nucleoside adenosine and nucleotides including adenine mononucleotides like ADP and ATP and dinucleotides such as P(1),P(4)-diadenosine tetraphosphate (Ap4A), and P(1),P(5)-diadenosine pentaphosphate (Ap5A) are present in different ocular locations and therefore they may contribute/modulate inflammatory processes. Adenosine receptors, in particular A2A adenosine receptors, present anti-inflammatory action in acute and chronic retinal inflammation. Regarding the A3 receptor, selective agonists like N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine (CF101) have been used for the treatment of inflammatory ophthalmic diseases such as dry eye and uveoretinitis. Sideways, diverse stimuli (sensory stimulation, large intraocular pressure increases) can produce a release of ATP from ocular sensory innervation or after injury to ocular tissues. Then, ATP will activate purinergic P2 receptors present in sensory nerve endings, the iris, the ciliary body, or other tissues surrounding the anterior chamber of the eye to produce uveitis/endophthalmitis. In summary, adenosine and nucleotides can activate receptors in ocular structures susceptible to suffer from inflammatory processes. This involvement suggests the possible use of purinergic agonists and antagonists as therapeutic targets for ocular inflammation.
AuthorsAna Guzman-Aranguez, Xavier Gasull, Yolanda Diebold, Jesús Pintor
JournalMediators of inflammation (Mediators Inflamm) Vol. 2014 Pg. 320906 ( 2014) ISSN: 1466-1861 [Electronic] United States
PMID25132732 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • CF101
  • Dinucleoside Phosphates
  • Receptors, Purinergic
  • P(1),P(5)-di(adenosine-5'-)pentaphosphate
  • Adenosine
Topics
  • Adenosine (analogs & derivatives, metabolism)
  • Animals
  • Dinucleoside Phosphates (metabolism)
  • Eye (immunology, metabolism)
  • Humans
  • Inflammation (immunology, metabolism)
  • Receptors, Purinergic (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: